Breath Analysis in Chronic Obstructive Lung Disease (COPD)

NCT02186639 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2018-03-29

No results posted yet for this study

Summary

To answer the question whether a disease specific profile of breath in patients with COPD can be detected by an untargeted metabolomic study using exhaled breath analysis by mass spectrometry.

Conditions

Sponsors & Collaborators

  • Swiss National Science Foundation

    collaborator OTHER
  • University of Zurich

    lead OTHER

Principal Investigators

  • Malcolm Kohler, Prof. · University Hospital Zurich, Pulmonary Division

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2016-12-31
Completion
2017-11-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02186639 on ClinicalTrials.gov